Baylor University Medical Center Proceedings最新文献

筛选
英文 中文
Optimization of rectal cancer surgery outcomes in the United States: the influence of hospital volume on rates of sphincter preservation before and after practice standardization. 美国直肠癌手术效果的优化:医院容积对执业标准化前后括约肌保留率的影响
Baylor University Medical Center Proceedings Pub Date : 2025-05-27 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2503653
Anthony C Waddimba, Wissam J Halabi, Gerald O Ogola, Chad C Griesbach, Katerina O Wells, Walter R Peters, James W Fleshman
{"title":"Optimization of rectal cancer surgery outcomes in the United States: the influence of hospital volume on rates of sphincter preservation before and after practice standardization.","authors":"Anthony C Waddimba, Wissam J Halabi, Gerald O Ogola, Chad C Griesbach, Katerina O Wells, Walter R Peters, James W Fleshman","doi":"10.1080/08998280.2025.2503653","DOIUrl":"10.1080/08998280.2025.2503653","url":null,"abstract":"<p><strong>Background: </strong>Multiple studies have found hospital-level proctectomy volumes to be associated with quality-of-care outcomes. The Consortium for Optimizing the Surgical Treatment of Rectal Cancer (OSTRiCh) was created in 2011 to spearhead quality standards. We investigated associations of facility-level proctectomy volumes with sphincter-preservation rates, as a rectal cancer surgery quality indicator, across the United States during 14 years before (1998-2011) and 3 years (2012-2014) into the OSTRiCh consortium.</p><p><strong>Methods: </strong>Low anterior and abdominoperineal resections for rectal cancer were identified from the National Inpatient Sample. Multivariable logistic regression with restricted cubic splines was used to test the association between annual proctectomy volumes per hospital and odds of sphincter-preserving resection.</p><p><strong>Results: </strong>We sampled 54,089 proctectomies performed during 1998 to 2014 in 5029 facilities that were 91.9% urban, 66.8% large, and 57.3% teaching hospitals. Recipients were 58.1% male, 70.6% White, 6.6% Black, 46.2% on Medicare, and 43.4% on commercial insurance. Mean age was 63.8 (±12.9) years. Across all study years, an optimum facility-level annual threshold of 30 proctectomies minimized sphincter-sacrificing resections. Analyses restricted to 2012 to 2014 suggested a lower annual optimum of 10 proctectomies per hospital. Higher facility-level proctectomy volume was associated with greater risk-adjusted odds of sphincter preservation in pre-OSTRiCh but not intra-OSTRiCh years.</p><p><strong>Conclusion: </strong>The association between higher facility-level proctectomy volume and sphincter preservation odds during prestandardization years had weakened by the early intra-OSTRiCh years.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"375-386"},"PeriodicalIF":0.0,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184134/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Avocations. 业余爱好。
Baylor University Medical Center Proceedings Pub Date : 2025-05-20 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2500855
Glen Couchman
{"title":"Avocations.","authors":"Glen Couchman","doi":"10.1080/08998280.2025.2500855","DOIUrl":"https://doi.org/10.1080/08998280.2025.2500855","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"398"},"PeriodicalIF":0.0,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184175/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes following ventricular tachycardia ablation in patients with end-stage kidney disease: US Renal Data System-based outcome data. 终末期肾病患者室性心动过速消融后的结果:基于美国肾脏数据系统的结果数据
Baylor University Medical Center Proceedings Pub Date : 2025-05-19 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2497203
Het Patel, Ashraf Alzahrani, Lillie Lamont, Ayeesha Kattubadi, David A Hamon, Edward M Powers, Peter D Farjo, Paari Dominic
{"title":"Outcomes following ventricular tachycardia ablation in patients with end-stage kidney disease: US Renal Data System-based outcome data.","authors":"Het Patel, Ashraf Alzahrani, Lillie Lamont, Ayeesha Kattubadi, David A Hamon, Edward M Powers, Peter D Farjo, Paari Dominic","doi":"10.1080/08998280.2025.2497203","DOIUrl":"10.1080/08998280.2025.2497203","url":null,"abstract":"<p><strong>Introduction: </strong>Data on the outcomes of ablation for paroxysmal ventricular tachycardia (VT) in patients with end-stage renal disease (ESRD) are lacking. This study aimed to identify outcomes of ablation in ESRD patients admitted with paroxysmal VT using the United States Renal Data System (USRDS).</p><p><strong>Method: </strong>All ESRD adult patients who were hospitalized with paroxysmal VT were included from the USRDS registry. Patients were stratified based on ablation treatment. Baseline characteristics were compared using descriptive statistics, and time-to-event analysis was done with a Kaplan-Meier curve. Cox regression analysis was used to assess hazard ratio (HR) for predictors of mortality.</p><p><strong>Results: </strong>A total of 8116 patients were identified. Of them, 688 [8.5%] received a VT ablation. Patients in the ablation group were more frequently younger and of African American descent compared to the no ablation group. VT ablation patients had a higher number of hospitalizations. Both groups had a 5-year mortality >75%; patients in the ablation group had a lower 5-year mortality rate (<i>P</i> < 0.001). Age ≥65 (HR 2.36), White race (HR 1.41), history of congestive heart failure (HR 1.40), and history of coronary artery disease (HR 1.73) were significantly associated with mortality.</p><p><strong>Conclusion: </strong>In selected patients with ESRD and paroxysmal VT, 5-year mortality was lower in those who received an ablation compared to no ablation.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"408-410"},"PeriodicalIF":0.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483014","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life in mycosis fungoides. 蕈样真菌病患者的生活质量。
Baylor University Medical Center Proceedings Pub Date : 2025-05-19 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2505368
Kirstin Altman, Oliver Ha
{"title":"Quality of life in mycosis fungoides.","authors":"Kirstin Altman, Oliver Ha","doi":"10.1080/08998280.2025.2505368","DOIUrl":"10.1080/08998280.2025.2505368","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"434-435"},"PeriodicalIF":0.0,"publicationDate":"2025-05-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184106/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483018","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How does mycosis fungoides affect quality of life? Comparative evaluation of the Dermatology Life Quality Index in patients with mycosis fungoides and psoriasis. 蕈样真菌病如何影响生活质量?蕈样真菌病与牛皮癣患者皮肤科生活质量指数的比较评价。
Baylor University Medical Center Proceedings Pub Date : 2025-05-16 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2500853
Funda Tamer, Yagmur Aypek, Esra Adisen
{"title":"How does mycosis fungoides affect quality of life? Comparative evaluation of the Dermatology Life Quality Index in patients with mycosis fungoides and psoriasis.","authors":"Funda Tamer, Yagmur Aypek, Esra Adisen","doi":"10.1080/08998280.2025.2500853","DOIUrl":"10.1080/08998280.2025.2500853","url":null,"abstract":"<p><strong>Background: </strong>Mycosis fungoides is a chronic cutaneous lymphoma that requires close follow up due to frequent recurrences. Although quality of life has an important role in cancer management, it is generally not evaluated in patients with mycosis fungoides. The Dermatology Life Quality Index (DLQI) questionnaire is a validated skin-specific quality of life index, with answers scored on a scale from 0 to 30. Higher scores are considered as demonstrating a high impact on quality of life. Herein, we compared DLQI scores in patients with mycosis fungoides and psoriasis.</p><p><strong>Methods: </strong>Medical records of patients admitted to the dermatology outpatient clinic between March 2023 and May 2023 were reviewed retrospectively. Afterward, the patients were contacted by phone to answer the questions on the DLQI.</p><p><strong>Results: </strong>This study included a total of 110 patients, 60 with psoriasis and 50 with mycosis fungoides. The median DLQI score was 4 (standard deviation [SD] 8) (range 0-24) in psoriasis patients and 1 (SD 4) (range 0-19) in patients with mycosis fungoides (<i>P</i> = 0.03). Psoriasis affected patients' quality of life more than mycosis fungoides in terms of symptoms and feelings (<i>P</i> = 0.03) and work or school (<i>P</i> = 0.04). However, the median DLQI was similar in patients with mycosis fungoides and psoriasis in terms of daily activities (<i>P</i> = 0.10), leisure (<i>P</i> = 0.28), personal relationships (<i>P</i> = 0.21), and treatment (<i>P</i> = 0.23). Moreover, skin lesions such as plaque and tumor, lesions on extremities, lymph node involvement, itching, pain, and systemic treatment were associated with high DLQI scores in patients with mycosis fungoides.</p><p><strong>Conclusion: </strong>Since various factors such as lesion type, lesion location, symptoms, and treatment significantly affect the DLQI, and DLQI subgroups were affected similarly to patients with psoriasis, we suggest considering DLQI scores when determining the most appropriate treatment option in patients with mycosis fungoides.</p>","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"427-433"},"PeriodicalIF":0.0,"publicationDate":"2025-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fontan and pregnancy: walking a tightrope. Fontan和怀孕:走钢丝。
Baylor University Medical Center Proceedings Pub Date : 2025-05-15 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2501904
Alysha Joseph, Weiyi Tan
{"title":"Fontan and pregnancy: walking a tightrope.","authors":"Alysha Joseph, Weiyi Tan","doi":"10.1080/08998280.2025.2501904","DOIUrl":"10.1080/08998280.2025.2501904","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"497-498"},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184128/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
National prevalence of melanoma: a cross-sectional analysis using the All of Us database. 黑色素瘤的全国患病率:使用我们所有人数据库的横断面分析。
Baylor University Medical Center Proceedings Pub Date : 2025-05-15 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2503633
Kritin K Verma, Jean E Pizano, Daniel P Friedmann, Cameron E West, Alba Posligua, Michelle B Tarbox, Daniel J Lewis
{"title":"National prevalence of melanoma: a cross-sectional analysis using the All of Us database.","authors":"Kritin K Verma, Jean E Pizano, Daniel P Friedmann, Cameron E West, Alba Posligua, Michelle B Tarbox, Daniel J Lewis","doi":"10.1080/08998280.2025.2503633","DOIUrl":"10.1080/08998280.2025.2503633","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"583-586"},"PeriodicalIF":0.0,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184111/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144483010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Avocations. 业余爱好。
Baylor University Medical Center Proceedings Pub Date : 2025-05-14 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2500854
Rolando M Solis
{"title":"Avocations.","authors":"Rolando M Solis","doi":"10.1080/08998280.2025.2500854","DOIUrl":"https://doi.org/10.1080/08998280.2025.2500854","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"420"},"PeriodicalIF":0.0,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macrophage activation syndrome complicating adult-onset Still's disease: the case for standardized guidelines. 巨噬细胞激活综合征并发成人发病斯蒂尔氏病:标准化指南的案例。
Baylor University Medical Center Proceedings Pub Date : 2025-05-14 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2498839
Samera Vaseer
{"title":"Macrophage activation syndrome complicating adult-onset Still's disease: the case for standardized guidelines.","authors":"Samera Vaseer","doi":"10.1080/08998280.2025.2498839","DOIUrl":"10.1080/08998280.2025.2498839","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"512-513"},"PeriodicalIF":0.0,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carvedilol: the magic bullet in cirrhosis. 卡维地洛:肝硬化的灵丹妙药。
Baylor University Medical Center Proceedings Pub Date : 2025-05-12 eCollection Date: 2025-01-01 DOI: 10.1080/08998280.2025.2501901
Ahmad Moussawi, Ranjeeta Bahirwani
{"title":"Carvedilol: the magic bullet in cirrhosis.","authors":"Ahmad Moussawi, Ranjeeta Bahirwani","doi":"10.1080/08998280.2025.2501901","DOIUrl":"10.1080/08998280.2025.2501901","url":null,"abstract":"","PeriodicalId":8828,"journal":{"name":"Baylor University Medical Center Proceedings","volume":"38 4","pages":"419-420"},"PeriodicalIF":0.0,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12184123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144482953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信